PROTEIN-C ACTIVITY, STAGE OF DISEASE, AND VASCULAR THROMBOSIS IN COLON-CARCINOMA

被引:12
作者
ELLIS, CN
BOGGS, HW
SLAGLE, GW
COLE, PA
COYLE, DJ
BLAKEMORE, WS
机构
[1] ALABAMA COLON & RECTAL INST,BIRMINGHAM,AL
[2] LOUISIANA STATE UNIV,MED CTR,SHREVEPORT,LA 71105
[3] SCHUMPERT MED CTR,SHREVEPORT,LA 71120
关键词
D O I
10.1016/0002-9610(92)90256-Q
中图分类号
R61 [外科手术学];
学科分类号
摘要
To determine the etiology of the increased incidence of postoperative deep venous thrombosis (DVT) in patients with carcinoma of the colon, serum levels of protein C were measured preoperatively in 65 patients with colorectal adenocarcinoma. Noninvasive lower-extremity Doppler studies were performed on all patients prior to discharge to assess patency of the deep veins. Six patients (9%) were found to have DVT. The protein C level was considered elevated if it was greater than 125% of control values and reduced if less than 75% of control values. The development of DVT was found to be independent of the serum carcinoembryonic antigen, albumin, total protein, hemoglobin, hematocrit, platelet count, prothrombin time, partial thromboplastin time, and the patient's age and percentage of ideal body weight. There was an inverse relationship between the protein C level (p < 0.001), Dukes stage of the tumor (p < 0.001), and the development of DVT. Linear regression analysis revealed that only the tumor stage and the protein C level could be used to predict the development of DVT. The data show that for these patients with colorectal malignancy, the development of DVT may be related to decreased levels of protein C.
引用
收藏
页码:78 / 82
页数:5
相关论文
共 33 条
[1]  
BENNICELLI JL, 1989, CANCER RES, V49, P930
[2]   CYTOKINE-INDUCED PROCOAGULANT ACTIVITY IN MONOCYTES AND ENDOTHELIAL-CELLS - FURTHER ENHANCEMENT BY CYCLOSPORINE [J].
CARLSEN, E ;
FLATMARK, A ;
PRYDZ, H .
TRANSPLANTATION, 1988, 46 (04) :575-580
[3]   A RANDOMIZED TRIAL OF ANTICOAGULATION WITH WARFARIN AND OF ALTERNATING CHEMOTHERAPY IN EXTENSIVE SMALL-CELL LUNG-CANCER BY THE CANCER AND LEUKEMIA GROUP-B [J].
CHAHINIAN, AP ;
PROPERT, KJ ;
WARE, JH ;
ZIMMER, B ;
PERRY, MC ;
HIRSH, V ;
SKARIN, A ;
KOPEL, S ;
HOLLAND, JF ;
COMIS, RL ;
GREEN, MR .
JOURNAL OF CLINICAL ONCOLOGY, 1989, 7 (08) :993-1002
[4]   DECREASE IN PROTEIN-C IN L-ASPARAGINASE-TREATED PATIENTS [J].
CONARD, J ;
HORELLOU, MH ;
VANDREDEN, P ;
POTEVIN, F ;
ZITTOUN, R ;
SAMAMA, M .
BRITISH JOURNAL OF HAEMATOLOGY, 1985, 59 (04) :725-727
[5]   TUMOR NECROSIS FACTOR SUPPRESSES TRANSCRIPTION OF THE THROMBOMODULIN GENE IN ENDOTHELIAL-CELLS [J].
CONWAY, EM ;
ROSENBERG, RD .
MOLECULAR AND CELLULAR BIOLOGY, 1988, 8 (12) :5588-5592
[6]   EFFECTS OF CYTOKINES ON VASCULAR ENDOTHELIUM - THEIR ROLE IN VASCULAR AND IMMUNE INJURY [J].
COTRAN, RS ;
POBER, JS .
KIDNEY INTERNATIONAL, 1989, 35 (04) :969-975
[7]   POTENTIAL ROLE OF INTERLEUKIN-1 AS THE TRIGGER FOR DIFFUSE INTRAVASCULAR COAGULATION IN ACUTE NONLYMPHOBLASTIC LEUKEMIA [J].
COZZOLINO, F ;
TORCIA, M ;
MILIANI, A ;
CAROSSINO, AM ;
GIORDANI, R ;
CINOTTI, S ;
FILIMBERTI, E ;
SACCARDI, R ;
BERNABEI, P ;
GUIDI, G ;
DIGUGLIELMO, R ;
PISTOIA, V ;
FERRARINI, M ;
NAWROTH, PP ;
STERN, D .
AMERICAN JOURNAL OF MEDICINE, 1988, 84 (02) :240-250
[8]  
DITTMAN WA, 1990, BLOOD, V75, P329
[9]  
DONATI MB, 1981, RECENT ADV BLOOD COA, V3, P375
[10]  
ESMON CT, 1989, J BIOL CHEM, V264, P4743